$0.80
+0.03 (+4.32%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+1,330.5% upside
Low Target
$7.11
Average Target
$11.39
High Target
$14.81
Current Price
$0.80
Current
$0.80
$0.80
Target
$11.39
$11.39
$7.11
$11.39 avg
$14.81
Scenario Analysis
Bear Case
$7.11
793.0%
Low target
Base Case
$11.39
+1,330.5%
Avg target
Bull Case
$14.81
+1,760.1%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$2.57
-69.0% from high
52-Week Low
$0.72
+11.2% from low
Target vs 52W High
$11.39
+343.2% vs high
Next Earnings Report
Aug 19, 2026
3d
until earnings
EPS Est: $-0.22
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | +3.3% |
| AMGN | Hold | 43 | 49% | $190.87 | -54.0% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +162.1% |
| VRTX | Strong Buy | 37 | 81% | $438.34 | -13.3% |
| REGN | Buy | 37 | 70% | $76.80 | -90.4% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -53.9% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -44.0% |
| BIIB | Buy | 43 | 67% | $91.45 | -56.4% |